Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 2003

View Archived Issues

Business highlights at Regeneron

Scancell and Celltech collaborate on antibody therapeutics to Lewis(y/b)

Levitra is effective in men of diverse ethnic origin

New NHE-3 inhibitors and their use covered by Merck KGaA patent

Merck KGaA presents novel PDE7 inhibitors

New PARP inhibitors in early development at Fujisawa

Dual 5-HT/noradrenaline uptake inhibitors and their use described by Lundbeck

MMP inhibitors, their preparation and biological evaluation reported by Sumitomo

Micrologix claims new L-nucleoside derivatives with anti-HBV activity

EP2 receptor agonist CP-533536 offers a therapeutic alternative for bone fractures and defects

E.U. orphan drug status awarded to Fidelin for adrenal insufficiency

Pivotal phase III trial for Cellegesic makes solid progress

CART-2 trial of AGI-1067 completes enrollment

Lapdap approved by U.K. agency for treatment of P. falciparum malaria

EFECT studies new breast cancer population for Faslodex

Quark Biotech and Fujisawa extend stroke collaboration

ACP-103 completes phase I testing

FDA panel recommends Onyx for treatment of arteriovenous malformations

Phase III study for RSD-1235 in atrial fibrillation commences dosing

Combination of NF-kB inhibitors and DNA-damaging agents for improving therapeutic outcome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...